Price $148.06 |
Market Cap
7.98B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
105.1
|
P/B
7.09
|
P/S
7.36
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
36.9
|
Op. Cash Flow
248.6K
|
FCF
4.8
|
|
Op. Margin
9.20%
|
Net Margin
7.50%
|
ROE
7.70%
|
ROI
2.70%
|
|
ROA
4.20%
|
EPS Growth
106.90%
|
Current Ratio
3.0
|
Debt/Equity
48.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| PetIQ Inc (PETQ) | $20.55 | - | - | 669.1M | Strong Buy |
| Lannett Company, Inc. (LCI) | $1.45 | - | - | 71.5M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.63 | - | - | 68.5M | Strong Buy |
| Akumin Inc (AKU) | $1.51 | - | - | 184.9M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $1.45 | - | - | 75M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
